Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Pharmacological characterization of DM232 (unifiram) and DM235 (sunifiram), new potent cognition enhancers Romanelli MN; Galeotti N; Ghelardini C; Manetti D; Martini E; Gualtieri FCNS Drug Rev 2006[Spr]; 12 (1): 39-52DM232 (unifiram) and DM235 (sunifiram) are potent cognition-enhancers, which are four order of magnitude more potent than piracetam. These compounds, although not showing affinity in binding studies for the most important central receptors or channels, are able to prevent amnesia induced by modulation of several neurotransmission systems. These compounds are able to increase the release of acetylcholine from rat cerebral cortex, and, as far as unifiram is concerned, to increase the amplitude of fEPSP in rat hippocampal slices. In vitro experiments, performed on hippocampal slices, also supported the hypothesis of a role of the AMPA receptors for the cognition-enhancing properties of unifiram and sunifiram.|Animals[MESH]|Central Nervous System/drug effects[MESH]|Cognition/*drug effects[MESH]|Dose-Response Relationship, Drug[MESH]|Humans[MESH]|In Vitro Techniques[MESH]|Nootropic Agents/*pharmacology/therapeutic use[MESH]|Piperazines/*pharmacology/therapeutic use[MESH]|Pyrroles/*pharmacology/therapeutic use[MESH]|Synaptic Transmission/drug effects[MESH] |